In the News
TeselaGen in the media — coverage and mentions from leading publications.
Two New Patents for Using AI to Accelerate Biotechnology
TeselaGen acquired two patents focused on leveraging generative and predictive AI models to optimize biological phenotypes, aiming to shorten the lengthy timelines typical in biotech R&D.
TeselaGen Biotechnology: Radically Accelerating Therapeutics Product Development In Over A $600 Billion Market
A profile of TeselaGen and CEO Eduardo Abeliuk covering the company's AI-powered platform for accelerating therapeutics, chemicals, and agricultural product development in a global biotech market valued at $1.45 trillion.
TeselaGen, JBEI Renew Biomanufacturing Partnership
TeselaGen and the DOE's Joint BioEnergy Institute extended their collaboration through a new five-year contract to develop renewable biofuels and bioproducts from nonfood plant materials.
TeselaGen's AI-Powered Platform Enables Biotech Innovation to Happen Faster and at Scale
A feature on TeselaGen's AI-powered software platform serving thousands of users across hundreds of institutions, delivering a 10x reduction in development costs and 7x increase in design and build speeds.
From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology
An examination of how AI is revolutionizing synthetic biology across five key areas: CRISPR gene editing, gene sequence optimization, protein design, metabolic pathway engineering, and automated experiment design.
On Biotech Engineering and AI: A Conversation with TeselaGen's CEO, Eduardo Abeliuk
An interview with Eduardo Abeliuk exploring how AI and machine learning are transforming biotech, including TeselaGen's partnership with NinthBio and the convergence of data science and biology.
Eduardo Abeliuk Of TeselaGen On The Future Of Artificial Intelligence
Dr. Eduardo Abeliuk discusses his perspectives on AI opportunities and risks, scientific discovery acceleration, AI explainability, and democratizing access to biotechnology tools for innovators globally.
AI-Enabled Design-and-Test Platform Speeds Bioproduct Development
TeselaGen's platform integrates software and AI-powered machine learning to accelerate bioproduct development, functioning as an operating system for biotech that connects with various vendor systems and lab equipment.
CDMOs Embrace Industry 4.0 to Satisfy Customer Demand
An industry analysis of how contract development and manufacturing organizations are adopting Industry 4.0 technologies, featuring TeselaGen CEO Eduardo Abeliuk on AI-driven optimization of biological product design.
How a Design-Build Software Firm Could Lead to a Coronavirus Vaccine
TeselaGen provided synthetic biology tools to Australian researchers at CSIRO and the University of Queensland working on a COVID-19 vaccine, using genetic code to create viral protein shells designed to trigger immune responses.
TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology
TeselaGen develops middleware software to accelerate the design-build-test cycle for laboratory researchers working with DNA constructs, positioned among emerging biotech-software companies leveraging declining DNA sequencing costs.
How Designer Microbes and the Organism Industry Will Reshape Our World
An exploration of how synthetic biology and bioCAD software platforms like TeselaGen are democratizing organism design, enabling rapid iteration and potentially unlocking garage-scale biotech ventures.
TeselaGen Wins Bio-IT World's 2013 Best Practices Award
TeselaGen received an honorable mention at the 2013 Bio-IT World Best Practices Awards for its cloud-based j5 platform that automates DNA assembly protocol design.
How To Code A Life
A feature exploring synthetic biology as a field mirroring software development, highlighting TeselaGen's aim to democratize genetic engineering by making academic tools accessible through web-based platforms.
TeselaGen To Accelerate Biotech Industry With J5
TeselaGen obtained an exclusive commercial license for the j5 gene assembly software from Berkeley Lab's JBEI, automating DNA assembly protocol design and dramatically reducing costs and timelines.
Try Tesela AI for free
Design libraries, generate protocols, and optimize experiments with AI agents. No credit card required.